Advances in nonviral dna vectors for gene therapy mdpi. Gene therapy market by vector type viral vector and non viral vector, gene type antigen, cytokine, tumor suppressor, suicide, deficiency, growth factors, receptors, and others, and application oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and other diseases. The viral gene delivery system shows a high transfection. Transposon technology is composed of one or two dna vectors cis or trans, respectively. Furthermore, physical approaches including, for example, electroporation and gene. Gene delivery based on non viral vectors has attracted much attention due to their universal application range and high safety level of delivery. By george kotzamanis, hassan abdulrazzak, athanassios kotsinas and vassilis g. The present vectors used for gene therapy are broadly classified as viral vectors, non viral. Non viral delivery systems in gene therapy and vaccine development. Viral vectors are widely used because of their natural ability to invade cells and deliver a manipulated genetic payload for therapeutic use. Designed as a volume in the translational oncology book series, cancer gene therapy by viral and non viral vectors deals with the practice of gene therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy.
Non viral vectors are simple in theory but complex in practice. Pluronicpolycation graftblock copolymers for gene delivery 243 x. Consequently, the majority of research into nonviral gene therapy has been focused on developing more ef. Pdf non viral vectors in gene therapy an overview murali. Pdf nonviral vectors are simple in theory but complex in practice. Apart from intra cellular and extracellular barriers, number of other. Viral and nonviral delivery systems for gene delivery. Frontiers gene therapy leaves a vicious cycle oncology.
Non viral vectors are safer, of low cost, more reproducible and do not present dna size limit. Gene therapy as part of modern molecular medicine holds great promise for the treatment of both acute and chronic diseases and has the potential to bring a revolutionary era to cancer treatment. Several vectors have been utilized for gene therapy and they are generally classified as nonviral and viral vectors. The most commonly used type of viral vector for gene therapy applications are adenoassociated viruses aav. Products required for cancer gene therapy include viral and non viral vectors. Nanoparticles as nonviral gene delivery vectors indian journal. Apart from intra cellular and extracellular barriers, number of other challenges also needs to be overcome in order to increase the effectiveness of non viral gene transfer. A delivery vehicle vector, of either viral or non viral origin, must be used to carry the foreign gene into a cell. Pdf uses of viral vectors have thus far eclipsed uses of nonviral vectors for gene therapy delivery in the clinic. Pdf nonviral vectors for genebased therapy researchgate. Therapeutic strategies such as gene replacementmutation correction, immune modulation and molecular therapysuicide gene therapy type approaches potentially offer unique and novel ways of fighting cancer, some of which have already shown promise in early clinical trials. The transposon technology is applied as a dna vector system for non viral delivery and insertion of therapeutic gene of interest goi from a donor dna vector into the recipient cell chromosome. Mediated gene therapy for prolonged expression perry b.
Non viral vectors in gene therapy an overview ncbi. Pdf chitosandna nanoparticles as nonviral vectors in gene. Although aav vectors are non pathogenic and safe, and found among the commonly used platforms for gene delivery in preclinical and clinical studies, their potential application in gene therapy is limited by the inability to deliver a therapeutic gene more than 5. Vectors are vehicles that ferry the genetic material into a wide variety of cells, tissues and whole organs. In the case of gene therapy vectors, the viral particles encapsulate a modified genome carrying a therapeutic gene cassette in place of the viral genome fig. Transduction is defined as the abortive non replicative or deadend infection that intro. Viruses can usually infect more than one type of cell. Toxicogenomics of non viral vectors for gene therapy. Viral and nonviral vectors in gene therapy sage journals. Transfection by means of nonviral gene delivery vectors is the. Gene therapy roadmap delaware bio science association.
Editorial nejat duzgunes of the 2210 gene therapy clinical trials reported until july 2015, only. A promising future to disease treatment by, damaris benny daniel i msc. The two major classes of methods are those that use recombinant viruses sometimes called biological nanoparticles or viral vectors and those that use naked dna or dna complexes non viral methods. Simplified illustration of mechanisms of action for in vivo and ex vivo gene therapy applications using viral and nonviral vectors for delivery to patients 2. Jul 06, 2012 although the risk of serious disease following natural adenovirus infection is rare and the viral genome would not integrate into the host genome, gene therapy by adenoviral vectors has caused serious bad side effects and even death of some patients. Delivery of toxic or immunostimu latory genes by viral and nonviral vectors has been investigated and encouraging results have been obtained in animal models. Lentiviral vectors are also being tested in gene therapy clinical trials. Cancer gene therapy market growth statistics forecasts 2025. Currently, the major drawback of gene therapy is the gene transfection rate.
Given these extremely valuable advantages offered by non viral compared to viral delivery systems, the realization of new non viral vectors able to overcome, or at least minimize, the drawbacks of those currently known is considered a fundamental result for the possible success of the gene therapy. Gene therapy generally refers to the delivery of dna into a patients cells to treat a target disease. Pdf advances in nonviral dna vectors for gene therapy. Today, both viral and nonviral vectors have seen a renaissance in innovative modi. Viral vectors are the most effective, but their application is limited by their immunogenicity, oncogenicity and the small size of the dna they can transport. Effects of pluronic block copolymers on gene transfer using naked dna 246 xi. Viral vectors, as the name indicates, uses modified viruses for the transfer of genetic material into the cells. Jan 01, 2015 vectors are vehicles that ferry the genetic material into a wide variety of cells, tissues and whole organs. Several vectors have been utilized for gene therapy and they are generally classified as non viral and viral vectors. In fact, 70% of gene therapy clinical tri als carried out so far have used. The optimal vector and delivery system depends on the target cells and its characteristics, duration of expression and the size of the genetic material to be incorporated in the vector 3,4. Gene delivery systems include viral vectors and non viral vectors.
Non viral gene therapy vectors carrying genomic constructs. Both viral and non viral vectors are being researched. Vectors for gene therapy viral and non viral viruses, liposomes, and naked dna are some of the vehicles used to introduce transgene into the host genome. The optimal vector and delivery system depends on the target cells and its characteristics, duration of expression and the size of the genetic. Nonviral vectors possess several advantages compared to the viral vectors. Main abbreviations 250 references 251 10 terplex gene delivery system 263 sung wan kim. Nonviral delivery systems in gene therapy intechopen. Cell and gene therapy insights nonviral vectors for gene therapy. The diversity of these systems highlights the recent progress of genebased therapy using nonviral approaches. The first approved gene therapy experiment occurred on september 14, 1990 in us, when ashanti desilva. The genetic and biological backgrounds of ocular diseases are well defined and so gene. Gene therapy is the introduction of genes into existing cells to prevent or cure a wide range of diseases. Gene therapy utilizes the delivery of dna into cells, which can be accomplished by several methods, summarized below.
The vehicles used to introduce the transgene is known as vectors, the utility of the vector depends on the factor enlisted below. It is a technique for correcting defective genes responsible for disease development. Nonviral vectors are far less efficient than viral vectors, but. Cancer gene therapy by viral and nonviral vectors wiley. The concept of gene therapy seems straightforward, but this is clearly an oversimplification, and numerous problems and risks exist that prevent gene therapy using viral vectors. Non viral vectors previously, low levels of transfection and expression of the gene held non viral methods at a disadvantage. This has resulted in low levels of usage in clinical trials. Non viral vectors have geared up the efficiency of cancer gene therapy. Today, both viral and non viral vectors have seen a renaissance in innovative modi. Of note, the performance of any gene delivery vector in vitro is. The two major classes of gene therapy are viral, which uses recombinant viruses to promote longterm or permanent genomic modification, and nonviral, which uses a naked dna plasmid to promote shortterm therapeutic protein expression locally at the site of drug administration.
Jul 15, 2014 the diversity of these systems highlights the recent progress of gene based therapy using non viral approaches. Non viral vectors possess several advantages compared to the viral vectors. Considerable segment growth can be attributed to the advantages possessed by viral vectors. Kenneth lundstrom, in novel approaches and strategies for biologics, vaccines and cancer therapies, 2015. Advances in genetics nonviral vectors for gene therapy. Possible mechanisms of pluronic effects o n gene delivery 248 xii. If a mutated gene causes a necessary protein to be faulty or missing, gene therapy may be able to introduce a normal copy of the gene to restore the function of the protein.
Non viral vectors segment is expected to foresee over 23% growth throughout the analysis timeframe. Therapy clinical trials has emphasized the potential of nucleic acidbased approaches to. The delivery of functional genes to target cells for achieving. Toxicogenomics of nonviral vectors for gene therapy. May 12, 2020 gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. Viral vectors have greater efficiency in terms of transferring genetic materials. Non viral sitespecific gene therapy via transposon systems. Viral vectors take advantage of the facile integration of the gene of interest into the host and high probability of its longterm. Non viral vector as vaccine carrier weihsu claire chen and leaf huang. Nanoparticles, nonviral vectors, gene therapy, transfection. The two main types of vectors that are used in gene therapy are based on viral or non viral gene delivery systems.
428 1506 886 1210 681 1326 1533 42 799 1030 1059 634 1320 1045 1020 776 1410 296 931 493 1163 717 1231 917 1235 1073 118 1369 1261 213 831 203 655 427